Memory T cells in transplantation: Generation, function, and potential role in rejection

American Journal of Transplantation

Volumn 4, Issue 6, 2004, Pages 846-852

  Bingaman, Adam W ^a   Farber, Donna L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Allografts; Alloimmunity; T lymphocytes

Indexed keywords

ALLOANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; CROSS REACTION; EPSTEIN BARR VIRUS; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MEMORY CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 2942536314     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00453.x     Document Type: Short Survey

References (74)

1. Cerny A, Ramseier H, Bazin H, Zinkernagel RM. Unimpaired first-set and second-set skin graft rejection in agammaglobulinemic mice. Transplantation 1988; 45: 1111-3.
2. Hall BM, Dorsch S, Roser B. The cellular basis of allograft rejection in vivo. II. The nature of memory cells mediating second set heart graft rejection. J Exp Med 1978; 148: 890-902.
3. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
4. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions [see comments]. Nature 1999; 401: 708-712.
5. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291: 2413-2417.
6. Farber DL, Commentary. Differential TCR signaling and the generation of memory T cells. J Immunol 1998; 160: 535-539.
7. Wang XN, Proctor SJ, Dickinson AM. Frequency analysis of recipient-reactive helper and cytotoxic T lymphocyte precursors using a combined single limiting dilution assay. Transpl Immunol 1996; 4: 247-251.
8. Ford WL, Atkins RC. The proportion of lymphocytes capable of recognizing strong transplantation antigens in vivo. Adv Exp Med Biol 1973; 29: 255-262.
9. Deacock SJ, Lechler RI. Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 1992; 54: 338-343.
10. Merkenschlager M, Terry L, Edwards, R Beverley, PC Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation. Eur J Immunol 1988; 18: 1653-1661.
11. Lombardi G, Sidhu S, Daly M, Batchelor JR, Makgoba W, Lechler RI. Are primary alloresponses truly primary? Int Immunol 1990; 2: 9-13.
12. Brehm MA, Markees TG, Daniels KA, Greiner DL, Rossini AA, Welsh RM. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 2003; 170: 4077-4086.
13. Pantenburg B, Heinzel F, Das L, Heeger PS, Valujskikh A. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 2002; 169: 3686-3693.
14. Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887-1895.
15. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 1994; 179: 1155-1161.
16. Burrows SR, Silins SL, Khanna R et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 1997; 27: 1726-1736.
17. Lombardi G, Sidhu S, Lamb JR, Batchelor JR, Lechler RI. Co-recognition of endogenous antigens with HLA-DR1 by alloreactive human T cell clones. J Immunol 1989; 142: 753-759.
18. lo cells are memory cells. Cell Immunol 1990; 130: 459-471.
19. Murali-Krishna K, Altman JD, Suresh M et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998; 8: 177-187.
20. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997; 278: 672-675.
21. Akbar AN, Terry L, Timms A, Beverley PC, Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988; 140: 2171-2178.
22. Bottomly K, Luqman M, Greenbaum L et al. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 1989; 19: 617-623.
23. Ahmadzadeh M, Hussain SF, Farber DL. Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells. J Immunol 2001; 166: 926-935.
24. Bradley LM, Watson SR, Swain SL. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J Exp Med 1994; 180: 2401-2406.
25. Wherry EJ, Teichgraber V, Becker TC et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4: 225-234.
26. Champagne P, Ogg GS, King AS et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410: 106-111.
27. Kivisakk P, Mahad DJ, Callahan MK et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A 2003; 100: 8389-8394.
28. Chalasani G, Dai Z, Konieczny BT, Baddoura FK, Lakkis FG. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 2002; 99: 6175-6180.
29. Kedl RM, Mescher MF. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. J Immunol 1998; 161: 674-683.
30. Cho BK, Wang C, Sugawa S, Eisen H, Chen J. Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A 1999; 96: 2976-2981.
31. Ahmadzadeh M, Hussain SF, Farber DL. Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo. J Immunol 1999; 163: 3053-3063.
32. Rogers PR, Dubey C, Swain SL. Qualitative changes accompany memory T cell generation. faster, more effective responses at lower doses of antigen. J Immunol 2000; 164: 2338-2346.
33. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen: memory cells are less dependent on accessory cell costimulation and can respond to many APC types including resting B cells. J Immunol 1994; 152: 2675-2685.
34. Dengler TJ, Pober JS. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000; 164: 5146-5155.
35. Hancock WW, Gao W, Shemmeri N et al. Immunopathogenesis of accelerated allograft rejection in sensitized recipients: humoral and nonhumoral mechanisms. Transplantation 2002; 73: 1392-1397.
36. Cecka JM. Living donor transplants. Clin Transpl 1995: 363-377.
37. Kobashigawa JA, Sabad A, Drinkwater D et al. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation? Circulation 1996; 94: 294-7.
38. Kupiec-Weglinski JW. Graft rejection in sensitized recipients. Ann Transplant 1996; 1: 34-40.
39. Heeger PS, Valujskikh A, Lehmann PV. Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen. J Immunol 2000; 165: 1278-1284.
40. Kersh EN, Kaech SM, Onami TM et al. TCR Signal Transduction in Antigen-Specific Memory CD8 T Cells. J Immunol 2003; 170: 5455-5463.
41. Krishnan S, Warke VG, Nambiar MP, Wong HK, Tsokos GC, Farber DL. Generation and biochemical analysis of human effector CD4 T cells. alterations in tyrosine phosphorylation and loss of CD3ζ expression. Blood 2001; 97: 3851-3859.
42. Hussain SF, Anderson CF, Farber DL. Differential SLP-76 Expression and TCR-Mediated Signaling in Effector and Memory CD4 T Cells. J Immunol 2002; 168: 1557-1565.
43. Robinson AT, Miller N, Alexander DR. CD3 antigen-mediated calcium signals and protein kinase C activation are higher in CD45RO+ than in CD45RA+ human T lymphocyte subsets. Eur J Immunol 1993; 23: 61-68.
44. Gupta M, Satyaraj E, Durdik JM, Rath S, Bal V. Differential regulation of T cell activation for primary versus secondary proliferative responses. J Immunol 1997; 158: 4113-4121.
45. Dai Z, Konieczny BT, Lakkis FG. The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells. J Immunol 2000; 165: 3031-3036.
46. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3: 269-279.
47. Goldrath AW, Sivakumar PV, Glaccum M et al. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002; 195: 1515-1522.
48. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002; 168: 4827-4831.
49. Becker TC, Wherry EJ, Boone D et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002; 195: 1541-1548.
50. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, Bradley LM. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003; 198: 1797-1806.
51. Li J, Huston G, Swain SL. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 2003; 198: 1807-1815.
52. Hancock WW, Wang L, Ye Q, Han R, Lee I. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003; 15: 479-486.
53. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813-1821.
54. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
55. Valujskikh A, Pantenburg B, Heeger PS. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002; 2: 501-509.
56. Williams MA, Onami TM, Adams AB et al. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J Immunol 2002; 169: 5387-5391.
57. Welsh RM, Markees TG, Woda BA et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol 2000; 74: 2210-2218.
58. London CA, Lodge MP, Abbas AK. Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 2000; 164: 265-272.
59. Sachs DH, Tolerance. of mice and men. J Clin Invest 2003; 111: 1819-1821.
60. Makhlouf L, Kishimoto K, Smith RN et al. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Diabetes 2002; 51: 3202-3210.
61. Okitsu T, Bartlett ST, Hadley GA, Drachenberg CB, Farney AC. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice. Am J Transplant 2001; 1: 138-145.
62. Cooke A, Phillips JM, Parish NM. Tolerogenic strategies to halt or prevent type 1 diabetes. Nat Immunol 2001; 2: 810-815.
63. Kreuwel HT, Aung S, Silao C, Sherman LA. Memory CD8 (+) T cells undergo peripheral tolerance. Immunity 2002; 17: 73-81.
64. Mirshahidi S, Huang CT, Sadegh-Nasseri S. Anergy in peripheral memory CD4 (+) T cells induced by low avidity engagement of T cell receptor. J Exp Med 2001; 194: 719-731.
65. Ahmadzadeh M, Farber DL. Functional plasticity of an antigen-specific memory CD4 T cell population. Proc Natl Acad Sci U S A 2002; 99: 11802-11807.
66. Dai Z, Li Q, Wang Y, Gao G et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310-317.
67. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 2003; 3: 609-620.
68. Yuan X, Salama AD, Dong V et al. The role of the CD134-CD134 ligand costimu(atory pathway in a((oimmune responses in vivo. J Immunol 2003; 170: 2949-2955.
69. Khayyamian S, Hutloff A, Buchner K et al. (COS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci U S A 2002; 99: 6198-6203.
70. Ellis CN, Krueger GG. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 2001; 345: 248-255.
71. Dedrick RL, Walicke P, Garovoy M. Anti-adhesion antibodies Efalizumab, a humanized anti-CD11a monoclonal antibody. Trans Immunol 2002; 9: 181-186.
72. Demirci G, Strom TB, Li XC. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms. J Immunol 2003; 171: 3878-3885.
73. Dutton RW, Bradley LM, Swain SL. T Cell memory. Ann. Rev. Immunol 1998; 16: 201-223.
74. + memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J Immunol 1992; 148: 324-331.